340 related articles for article (PubMed ID: 30041677)
1. miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma.
Gu Y; Liu H; Kong F; Ye J; Jia X; Zhang Z; Li N; Yin J; Zheng G; He Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):164. PubMed ID: 30041677
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling.
Yang ZH; Li J; Chen WZ; Kong FS
Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539
[TBL] [Abstract][Full Text] [Related]
3. miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1.
Jia LF; Huang YP; Zheng YF; Lyu MY; Wei SB; Meng Z; Gan YH
Oral Oncol; 2014 Nov; 50(11):1062-71. PubMed ID: 25127200
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
5. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells.
Jiang L; Liu X; Chen Z; Jin Y; Heidbreder CE; Kolokythas A; Wang A; Dai Y; Zhou X
Biochem J; 2010 Nov; 432(1):199-205. PubMed ID: 20819078
[TBL] [Abstract][Full Text] [Related]
7. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
Tian X; Zeng G; Li X; Wu Z; Wang L
Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
[TBL] [Abstract][Full Text] [Related]
8. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
Ding J; Yang C; Yang S
J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of AKT1, a miR-138 target gene, is involved in the migration and invasion of tongue squamous cell carcinoma.
Ji M; Wang W; Yan W; Chen D; Ding X; Wang A
J Oral Pathol Med; 2017 Oct; 46(9):731-737. PubMed ID: 28122142
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.
Wu X; Gong Z; Sun L; Ma L; Wang Q
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28319306
[TBL] [Abstract][Full Text] [Related]
11. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4.
Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K
Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0081069 facilitates tongue squamous cell carcinoma progression by modulating MAP2K4 expression via miR-634.
Pan C; Su Z; Xie H; Ning Y; Li S; Xiao H
Odontology; 2023 Apr; 111(2):474-486. PubMed ID: 36181561
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
14. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
Jia LF; Gan YH; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
[TBL] [Abstract][Full Text] [Related]
17. Targeting miR-21 with AS-miR-21 suppresses aggressive growth of human tongue squamous cell carcinoma in vivo.
Wang Y; Zhu Y; Lv P; Li L
Int J Clin Exp Pathol; 2015; 8(5):4773-81. PubMed ID: 26191167
[TBL] [Abstract][Full Text] [Related]
18. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS.
Han J; Wang L; Wang X; Li K
Med Sci Monit; 2016 Feb; 22():522-9. PubMed ID: 26883054
[TBL] [Abstract][Full Text] [Related]
20. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
Chi H
Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
